RAHIM, Nigmat. Bispecific CAR-T vs. BCMA-Specific CAR-T: Advancing Treatment for Relapsed/Refractory Multiple Myeloma. Highlights in Science, Engineering and Technology, [S. l.], v. 153, p. 42–47, 2025. DOI: 10.54097/wvmnsh51. Disponível em: https://hsetarchive.drpconf.org/index.php/ojs/article/view/1041. Acesso em: 20 nov. 2026.